Literature DB >> 7912980

Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised.

K A Hossmann1.   

Abstract

Neuronal injury following focal cerebral ischemia is widely attributed to the excitotoxic effects of glutamate. However, critical analysis of published data on glutamate toxicity in vitro and the comparison of these data with in vivo release of glutamate and the therapeutic effect of glutamate antagonists raises doubts about a neurotoxic mechanism. An alternative explanation for glutamate-mediated injury is hypoxia due to peri-infarct spreading depression-like depolarizations. These depolarizations are triggered in the core of the ischemic infarct and spread at irregular intervals into the peri-infarct surrounding. In ischemically uncompromised tissue, the metabolic workload associated with spreading depression is coupled to an increase in blood flow and oxygen supply, assuring maintenance of oxidative respiration. In the penumbra region of focal ischemia, the hemodynamic constraints of collateral blood circulation prevail the adequate adjustment of oxygen delivery, leading to transient episodes of relative tissue hypoxia. The hypoxic episodes cause a suppression of protein synthesis, a gradual deterioration of energy metabolism and a progression of irreversibly damaged tissue into the penumbra zone. The generation of peri-infarct spreading depressions and the associated metabolic workload can be suppressed by NMDA and non-NMDA antagonists. As a result, the penumbral inhibition of protein synthesis and the progressing energy failure is also prevented, and the volume of ischemic infarct decreases. Interventions to improve ischemic resistance should therefore aim at improving the oxygen supply or reducing the metabolic workload in the penumbra region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912980     DOI: 10.1111/j.1750-3639.1994.tb00808.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  34 in total

1.  Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina.

Authors:  Claudio Macaluso; Laura J Frishman; Beatrice Frueh; Alain Kaelin-Lang; Shoken Onoe; Günter Niemeyer
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

2.  Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

Authors:  P F Behrens; H Langemann; R Strohschein; J Draeger; J Hennig
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

3.  Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.

Authors:  Dirk M Hermann
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 4.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

5.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

Authors:  C Iadecola; K Niwa; S Nogawa; X Zhao; M Nagayama; E Araki; S Morham; M E Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity.

Authors:  Y Kitao; K Ozawa; M Miyazaki; M Tamatani; T Kobayashi; H Yanagi; M Okabe; M Ikawa; T Yamashima; D M Stern; O Hori; S Ogawa
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

7.  Contribution of a mitochondrial pathway to excitotoxic neuronal necrosis.

Authors:  Dae-Won Seo; Maria-Leonor Lopez-Meraz; Suni Allen; Claude Guy Wasterlain; Jerome Niquet
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

8.  Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection.

Authors:  Jed A Hartings; Michael L Rolli; X-C May Lu; Frank C Tortella
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

9.  Quadruple H therapy for vasospasm.

Authors:  M Sami Walid; Nadezhda V Zaytseva
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

Review 10.  Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.

Authors:  Gang Cheng; Rong-hua Kong; Lei-ming Zhang; Jian-ning Zhang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.